title: Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).
abstract: BACKGROUND
  Most patients with cancers of the nasal cavity or paranasal sinuses are candidates of radiation therapy either due incomplete resection or technical inoperability. Local control in this disease is dose dependent but technically challenging due to close proximity of critical organs and accompanying toxicity. Modern techniques such as IMRT improve toxicity rates while local control remains unchanged. Raster-scanned carbon ion therapy with highly conformal dose distributions may allow higher doses at comparable or reduced side-effects.
  
  
  METHODS
  The IMRT-HIT-SNT trial is a prospective, mono-centric, phase II trial evaluating toxicity (primary endpoint: mucositis ≥ CTCAE°III) and efficacy (secondary endpoint: local control, disease-free and overall survival) in the combined treatment with IMRT and carbon ion boost in 30 patients with histologically proven (≥R1-resected or inoperable) adeno-/or squamous cell carcinoma of the nasal cavity or paransal sinuses. Patients receive 24 GyE carbon ions (8 fractions) and IMRT (50 Gy at 2.0 Gy/fraction).
  
  
  CONCLUSIONS
  The primary objective of IMRT-HIT-SNT is to evaluate toxicity and feasibility of the proposed treatment in sinonasal malignancies.
  
  
  BACKGROUND
  Clinical trial identifier NCT 01220752.
authors: Dept. of Radiation Oncology, INF 400, 69120 Heidelberg, Germany. alexandra.jensen@med.uni-heidelberg.de
authors: Alexandra D
authors: AD
authors: Jensen
authors: Anna V
authors: AV
authors: Nikoghosyan
authors: Christine
authors: C
authors: Windemuth-Kieselbach
authors: Jürgen
authors: J
authors: Debus
authors: Marc W
authors: MW
authors: Münter
references: Radiology. 1972 Sep;104(3):629-34
references: 4626287
references: Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):763-9
references: 18395361
references: Control Clin Trials. 1989 Mar;10(1):1-10
references: 2702835
references: Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1042-50
references: 17570610
references: Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):147-54
references: 14697432
references: Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):151-7
references: 17189068
references: Ann Oncol. 2003 Mar;14(3):367-72
references: 12598339
references: Cancer. 2001 Dec 15;92(12):3012-29
references: 11753979
references: Am J Clin Oncol. 2010 Dec;33(6):595-8
references: 20142725
references: Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):158-68
references: 12694834
references: Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1343-51
references: 18963535
references: Int J Radiat Oncol Biol Phys. 1988 Jan;14(1):11-22
references: 3335447
references: Head Neck. 2008 Jul;30(7):925-32
references: 18302261
references: Head Neck. 2009 Oct;31(10):1297-308
references: 19536762
references: Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):141-7
references: 17459609
references: Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):424-32
references: 18755554
references: J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
references: 10655437
references: Head Neck Surg. 1979 Sep-Oct;2(1):3-11
references: 400658
references: Clin Otolaryngol Allied Sci. 1980 Jun;5(3):195-211
references: 6996871
references: Radiother Oncol. 2003 Jan;66(1):11-8
references: 12559516
references: Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):338-43
references: 18207030
references: Radiother Oncol. 1999 Jun;51(3):215-8
references: 10435816
references: Am J Clin Oncol. 2009 Jun;32(3):296-303
references: 19433966